Phase I Randomized Study of Cardiac Stem Cells in Patients With Hypoplastic Left Heart Syndrome: The CHILD Trial.

Saved in:
Bibliographic Details
Title: Phase I Randomized Study of Cardiac Stem Cells in Patients With Hypoplastic Left Heart Syndrome: The CHILD Trial.
Authors: Kaushal S; Department of Surgery, University of Nevada, Las Vegas, Las Vegas, Nevada, USA. Electronic address: sunjaykaushal008@gmail.com., Hare JM; Interdisciplinary Stem Cell Institute and Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA., Mahle WT; Children's Healthcare of Atlanta, Atlanta, Georgia, USA; Division of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Khan A; Interdisciplinary Stem Cell Institute and Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA., Ohye RG; Section of Pediatric Cardiovascular Surgery, Department of Cardiac Surgery, University of Michigan Medical School, Ann Arbor, Michigan, USA., Slesnick TC; Children's Healthcare of Atlanta, Atlanta, Georgia, USA; Division of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Chai PJ; Division of Cardiothoracic Surgery, Department of Surgery, Children's Healthcare of Atlanta, Atlanta, Georgia, USA; Emory University, Atlanta, Georgia, USA., Shashidharan S; Division of Cardiothoracic Surgery, Department of Surgery, Children's Healthcare of Atlanta, Atlanta, Georgia, USA; Emory University, Atlanta, Georgia, USA., Robinson JD; Department of Pediatrics, Division of Pediatric Cardiology, Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois, USA., Jone PN; Department of Pediatrics, Division of Pediatric Cardiology, Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois, USA., Doman T; Section of Pediatric Cardiovascular Surgery, Department of Cardiac Surgery, University of Michigan Medical School, Ann Arbor, Michigan, USA., Si MS; Division of Cardiac Surgery, Department of Surgery, David Geffen School of Medicine University of California-Los Angeles, Los Angeles, California, USA., Lu JC; Department of Pediatrics, Division of Pediatric Cardiology University of Michigan Medical School, Ann Arbor, Michigan, USA., Bacallao K; Interdisciplinary Stem Cell Institute and Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA., Nettina AE; Interdisciplinary Stem Cell Institute and Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA., Lamazares R; Interdisciplinary Stem Cell Institute and Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA., Saltzman RG; Interdisciplinary Stem Cell Institute and Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA., Simpson LM; Coordinating Center for Clinical Trials, Department of Biostatistics and Data Science, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas, USA., Li R; Coordinating Center for Clinical Trials, Department of Biostatistics and Data Science, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas, USA., Bettencourt JE; Coordinating Center for Clinical Trials, Department of Biostatistics and Data Science, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas, USA., Mansoor K; Coordinating Center for Clinical Trials, Department of Biostatistics and Data Science, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas, USA., Davis BR; Coordinating Center for Clinical Trials, Department of Biostatistics and Data Science, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas, USA., Deatrick KB; Department of Cardiac Surgery, University of Michigan Medical School, Ann Arbor, Michigan, USA., Yang J; Blalock-Taussig-Thomas Congenital Heart Center, Department of Pediatrics, Johns Hopkins University, Baltimore, Maryland, USA., Mishra R; Secretome Therapeutics, Baltimore, Maryland, USA., Everett AD; Blalock-Taussig-Thomas Congenital Heart Center, Department of Pediatrics, Johns Hopkins University, Baltimore, Maryland, USA., Lai D; Coordinating Center for Clinical Trials, Department of Biostatistics and Data Science, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas, USA., Davis ME; Wallace H. Coulter Department of Biomedical Engineering, Emory School of Medicine, Atlanta, Georgia, USA. Electronic address: michael.davis@bme.gatech.edu.
Source: JACC. Heart failure [JACC Heart Fail] 2026 Jan; Vol. 14 (1), pp. 102723. Date of Electronic Publication: 2025 Nov 19.
Publication Type: Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial; Multicenter Study
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101598241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-1787 (Electronic) Linking ISSN: 22131779 NLM ISO Abbreviation: JACC Heart Fail Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2213-1787
DOI:10.1016/j.jchf.2025.102723